LFB Biotechnologies, SAS Report issue

Founded: Framingham MA United States (1993)
Status: No NME R&D (1993)

Organization Overview

First Clinical Trial
2002
NCT00056550
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

LFB BIOMEDICAMENTS | LFB USA, Inc. | rEVO Biologics